Cargando…
Annual reports in medicinal chemistry. Volume 32.
Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expectedto provide the basis for entirely new future therapies.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego, Calif. ; London :
Academic Press,
1997.
|
| Colección: | Annual reports in medicinal chemistry ;
v. 32 |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Annual Report in Medicinal Chemistry, Volume 32; Copyright Page; CONTENTS; CONTRIBUTORS; PREFACE; SECTION I: CENTRAL NERVOUS SYSTEM DISEASES; Chapter 1. Recent Advances in Migraine Therapy; Chapter 2. Alzheimer's Disease: Recent Advances on the Amyloid Hypothesis; Chapter 3. Obesity: Leptin
- Neuropeptide Y Interactions in the Control of Body Weight; Chapter 4. Melatonin Receptor Ligands and Their Potential Clinical Applications; Chapter 5. Corticotropin-Releasing Hormone (CRH) Receptors and the Discovery of Selective Non-Peptide CRH, Antagonists
- Chapter 6. Recent Advances in Neurokinin Receptor AntagonistsSECTION II: CARDIOVASCULAR AND PULMONARY DISEASES; Chapter 7. Endothelin Inhibitors; Chapter 8. Antithrombotics/Serins Proteases; Chapter 9. Leukotriene Modulators as Therapeutic Agents in Asthma and Other Inflammatory Diseases; Chapter 10. Emerging Opportunities in the Treatment of Atherosclerosis; SECTION III: CANCER AND INFECTIOUS DISEASES; Chapter 11. New Approaches and Agents to Overcome Bacterial Resistance; Chapter 12. Bacterial Genomics and the Search for Novel Antibiotics
- Chapter 13. Resistance to Antiretroviral Drug TherapyChapter 14. Non-HIV Antiviral Agents; Chapter 15. Recent Advances in Antifungal Agents; Chapter 16. Angiogenesis Inhibitors; Chapter 17. Chemical Inhibitors of Cyclin-Dependent Kinases; SECTION IV: IMMUNOLOGY, ENDOCRINOLOGY AND METABOLIC DISEASES; Chapter 18. T Lymphocyte Potassium Channel Blockers; Chapter 19. Male Contraception; Chapter 20. New Dermatological Agents for the Treatment of Psoriasis; Chapter 21. Selective Cyclooxygenase-2 Inhibitors; Chapter 22. Growth Hormone Secretagogues; SECTION V: TOPICS IN BIOLOGY
- Chapter 23. Novel Gene Switches for the Regulation of Gene ExpressionChapter 24. Agents that Block TNF-a Synthesis or Activity; Chapter 25. Nuclear Orphan Receptors: Scientific Progress and Therapeutic; SECTION VI: TOPICS IN DRUG DESIGN AND DISCOVERY; Chapter 26. Discovery and Identification of Lead Compounds from Combinatorial Mixtures; Chapter 27. Electrospray Mass Spectrometic Characterization of Adducts Between 269 Therapeutic Agents and Proteins; Chapter 28. Nonpeptide Agonists for Peptide Receptors: Lessons from Ligands
- Chapter 29. Natural Products Research and Pharmaceuticals in the 1990'sChapter 30. Inhibition of Cytochrome P-450 and Implications in Drug Development; SECTION VII: TRENDS AND PERSPECTIVES; Chapter 31. To Market, To Market
- 1996; COMPOUND NAME, CODE NUMBER AND SUBJECT INDEX, VOLUME 32; CUMULATIVE CHAPTER TITLES KEYWORD INDEX, VOLUMES 1-32; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1996; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1996, (BY INDICATION)